SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HTFL

Heartflow, Inc. (HTFL)

NASDAQ: HTFL · USD
Healthcare · Health Information Services
$45.89-$1.18 (-2.51%)
 
Market cap
$4.03B
Insider Score
Analyst consensus
Market Cap$4.03B+72.3%
Revenue (ttm)$238.66M
Net Income-$79.02M
EPS$0.67
Shares Out87.89M
PE Ratio68.49
Forward PE-173.07
Dividendn/a
Ex-Dividend Daten/a
Volume1,332,668
Open$46.37
Previous Close$47.07
Day's Range$44.92 - $47.60
52-Week Range$20.13 - $60.66
Betan/a
AnalystsStrong Buy
Price Target$65.00(+41.64%)
Earnings DateNov 12, 2026

About HTFL

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Address
135 Main Street, San Francisco, CA, 94105, United States
Market Cap
4.03 billion
Employees
843
Industrial Classification
Health Information Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$16.22M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
2 Buy0 Hold0 SellAvg target $52.20 (+10.9%)

2 firms rating HTFL in the last 3 months, one vote each. Issuer-paid research is not counted.

1 Day
+0.45%
5 Days
-15.65%
1 Month
-7.74%
6 Months
+76.95%
1 Year
+72.35%

$HTFL stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in HTFL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by HTFL's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

HTFL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New HTFL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to HTFL from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from HTFL’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Q3 revenue surged 57% with guidance raised; analyst upgraded price target $45→$70 with Buy maintained; adjusted losses narrowed despite GAAP loss.

Recent Insider Activity

Buys
0
Sells
17
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-38.0 since Aug 21
0255075100Aug 21 — Insider Score 38.0Aug 22 — Insider Score 38.0Aug 23 — Insider Score 38.0Aug 24 — Insider Score 38.0Aug 25 — Insider Score 38.0Aug 26 — Insider Score 38.0Aug 27 — Insider Score 38.0Aug 28 — Insider Score 38.0Aug 29 — Insider Score 38.0Aug 30 — Insider Score 37.0Aug 31 — Insider Score 37.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 31.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

HEALGlobal X HealthTech ETF3.21%
HLTHTema Healthcare AI ETF1.90%
PTHInvesco Dorsey Wright Healthcare Momentum ETF1.51%
EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF1.21%
HYPGolden Eagle Dynamic Hypergrowth ETF1.21%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.63%
FSEGFidelity Enhanced Small Cap Growth ETF0.52%
IHFiShares U.S. Healthcare Providers ETF0.49%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.47%
AIMSAcuitas Small Cap Active ETF0.42%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.37%
FESMFidelity Enhanced Small Cap ETF0.37%

Weight is the stock’s share of each fund’s holdings.